0001209191-18-056986.txt : 20181102 0001209191-18-056986.hdr.sgml : 20181102 20181102180031 ACCESSION NUMBER: 0001209191-18-056986 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20181031 FILED AS OF DATE: 20181102 DATE AS OF CHANGE: 20181102 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: BEHRENS M KATHLEEN CENTRAL INDEX KEY: 0001211701 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-14895 FILM NUMBER: 181158276 MAIL ADDRESS: STREET 1: 6701 KAISER DRIVE CITY: FREMONT STATE: CA ZIP: 94555 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Sarepta Therapeutics, Inc. CENTRAL INDEX KEY: 0000873303 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 930797222 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 215 FIRST STREET STREET 2: SUITE 415 CITY: CAMBRIDGE STATE: MA ZIP: 02142 BUSINESS PHONE: 617-274-4000 MAIL ADDRESS: STREET 1: 215 FIRST STREET STREET 2: SUITE 415 CITY: CAMBRIDGE STATE: MA ZIP: 02142 FORMER COMPANY: FORMER CONFORMED NAME: Sarepta Therapuetics, Inc. DATE OF NAME CHANGE: 20120712 FORMER COMPANY: FORMER CONFORMED NAME: AVI BIOPHARMA INC DATE OF NAME CHANGE: 19980930 FORMER COMPANY: FORMER CONFORMED NAME: ANTIVIRALS INC DATE OF NAME CHANGE: 19970123 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2018-10-31 0 0000873303 Sarepta Therapeutics, Inc. SRPT 0001211701 BEHRENS M KATHLEEN 215 FIRST STREET, SUITE 415 CAMBRIDGE MA 02142 1 0 0 0 Common Stock 2018-10-31 4 M 0 10000 3.96 A 126534 D Common Stock 2018-10-31 4 S 0 10000 131.71 D 116534 D Common Stock 21855 I By Trust Stock Option (right to buy) 3.96 2018-10-31 4 M 0 10000 0.00 D 2019-03-31 Common Stock 10000 0 D The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $131.53 to $131.94, inclusive. The reporting person undertakes to provide to Sarepta Therapeutics, Inc., any security holder of Sarepta Therapeutics, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price with the range set forth herein. The option to purchase shares is fully vested. /s/ David Tyronne Howton, as attorney-in-fact for M. Kathleen Behrens 2018-11-02